Substance P increases in vitro lymphokine-activated-killer (LAK) cell cytotoxicity against fresh colorectal cancer cells
- 30 November 1992
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 53 (5) , 445-449
- https://doi.org/10.1016/0022-4804(92)90088-h
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neuropeptide-immunoreactive cells in human thymusBrain, Behavior, and Immunity, 1990
- Stimulation of Human B Lymphocyte Differentiation by the Neuropeptides Substance P and Neurokinin AScandinavian Journal of Immunology, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Modulating Effect of Beta-Endorphin, Somatostatin, Substance P and Vasoactive Intestinal Peptide on the Proliferative Response of Peripheral Blood T Lymphocytes of Nickel-Allergic Patients to Nickel SulfateInternational Archives of Allergy and Immunology, 1986
- Influence of Beta-Endorphin, Somatostatin, Substance P and Vasoactive Intestinal Peptide on the Proliferative Response of Human Peripheral Blood T Lymphocytes to Mercuric ChlorideInternational Archives of Allergy and Immunology, 1986
- Substance P recognition by a subset of human T lymphocytes.Journal of Clinical Investigation, 1984
- A rapid technique for isolation of viable tumor cells from solid tumors: Use of the tumor cells for induction and measurement of cell-mediated cytotoxic responsesEuropean Journal of Cancer and Clinical Oncology, 1982
- Substance P antagonistsTrends in Neurosciences, 1982
- Chemical design of antagonists of substance PActa Physiologica Scandinavica, 1981
- Isolation and functional characterization of human intestinal mucosal lymphoid cells.Journal of Clinical Investigation, 1977